Published in
Elsevier, European Journal of Cancer, (120), p. 20-30, 2019
DOI: 10.1016/j.ejca.2019.06.023
Links
Tools
Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial
Journal article published in 2019 by
Mark Robson 
,
Kathryn J. Ruddy ,
Seock-Ah Im ,
Elżbieta Senkus ,
Binghe Xu,
Susan M. Domchek,
Norikazu Masuda,
Wei Li,
Nadine Tung,
Anne Armstrong,
Suzette Delaloge,
Wendy Bannister,
Carsten Goessl,
Arnold Degboe,
Robert Hettle
and other authors.
,
Kathryn J. Ruddy ,
Seock-Ah Im ,
Elżbieta Senkus ,
Binghe Xu,
Susan M. Domchek,
Norikazu Masuda,
Wei Li,
Nadine Tung,
Anne Armstrong,
Suzette Delaloge,
Wendy Bannister,
Carsten Goessl,
Arnold Degboe,
Robert Hettle
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 